SHMN SOHM Inc (PK)

SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, today announced financial results for the Company's fiscal first quarter 2013, ended March 31, 2013. Revenue in the fiscal first quarter of 2013 was $1,005,410 compared to revenue of $375,741 for the same quarter of 2012. This exceptional growth of 267% became possible because of concerted effort in developing the OTC Generic Drug business and launch of FoHM by SOHM, our flagship skincare line in USA.

Shailesh Shah, President and CEO of SOHM, Inc., stated, "During the year 2012 SOHM continued to create infrastructure to manufacture profile pouches of OTC drugs for one of USA based buyer. This buyer has nationwide distribution network of over 1500 warehouse stores. All the efforts put in this started generating the revenues during 2013." Mr. Shah further stated that "Besides this, launch of FOHM, foam based face wash, powered by Salic-2 has started contributing to the revenues of SOHM."

ABOUT US

SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Besides Generic Drugs, SOHM also has manufacturing facilities for Food Supplements and Cosmetics. The Company's global headquarters is located in California, USA, with manufacturing facilities in India. SOHM, Inc. exports generic pharmaceuticals globally, with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com

SAFE HARBOR STATEMENT

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

For More Information Contact Investor Relations At 714-522-6700